Prevention of diabetes: a strategic approach for individual patients
Authors:
Open Access
- 28 December 2012
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 28 (s2) , 79-84
Abstract
Summary: The ‘diabetes epidemic’ is an important health and socioeconomic problem worldwide. Type 2 diabetes is a chronic disease with gradual deterioration in glucose metabolism which causes multiple systemic complications. Therefore, early intervention in the prediabetic stage is a valuable approach to reduce diabetes development and related complications. Many clinical trials have suggested that lifestyle intervention, including moderate‐intensity exercise and diet control, and pharmacologic intervention using metformin, α‐glucosidase inhibitors, thiazolidinediones, anti‐obesity drugs and incretin mimics, are effective in preventing diabetes development. However, an individualized approach with careful consideration of the patient’s risk status and health economics is needed to perform a successful intervention programmes. In this review, we will summarize the known evidence on treatment‐ and cost‐effectiveness of drug and lifestyle treatment. Additionally, we will propose a strategic approach algorithm that is applicable to clinical practice.Keywords
This publication has 40 references indexed in Scilit:
- Diabetes in AsiaJAMA, 2009
- Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose toleranceThe Lancet, 2009
- Impaired Fasting Glucose and Impaired Glucose ToleranceDiabetes Care, 2007
- Epidemic obesity and type 2 diabetes in AsiaThe Lancet, 2006
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE StudyDiabetologia, 2004
- Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?Archives of internal medicine (1960), 2004
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001